HCW Biologics Inc. (HCWB)

NASDAQ: HCWB · Real-Time Price · USD

2.510

-0.430 (-14.63%)

At close: Sep 8, 2026, 4:00 PM EDT

2.630

+0.120 (4.78%)

After-hours: Sep 8, 2026, 5:10 PM EDT

HCW Biologics Employees

HCW Biologics had 35 employees as of December 31, 2025. The number of employees decreased by 1 or -2.78% compared to the previous year.

Employees

35

Change (1Y)

-1

Growth (1Y)

-2.78%

Revenue / Employee

$192,034

Profits / Employee

-$611,719

Market Cap

4.61M

Employees Chart

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2025	35	-1	-2.78%
Dec 31, 2024	36	-9	-20.00%
Dec 31, 2023	45	1	2.27%
Dec 31, 2022	44	0	-
Dec 31, 2021	44	4	10.00%
Mar 31, 2021	40	-	-
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro

Related Stocks

Company Name	Employees
Cardio Diagnostics Holdings	17
Processa Pharmaceuticals	12
NuCana	12
Purple Biotech	10
Dermata Therapeutics	9
Enveric Biosciences	6
Can-Fite BioPharma	5
XTL Biopharmaceuticals	5

Employee Rankings

HCWB News

8 hours ago - HCW Biologics enters exclusive HCW11-006 distribution pact with Akron Biotech - TheFly
8 hours ago - HCW Biologics Entered an Exclusive Distribution Agreement with Akron Biotech to Commercialize HCW11-006 as Reagent Used to Support Production of Highly Functional Human CAR-T Cells - GlobeNewsWire
9 hours ago - HCW Biologics Proxy statement: Proxy filing - Filings
6 days ago - HCW Biologics receives patent allowance for alopecia areata drug - TheFly
6 days ago - HCW Biologics Strengthens U.S. Patent Estate for Its Lead Clinical-Stage Immunotherapeutic HCW9302 as Alopecia Areata Treatment - GlobeNewsWire
11 days ago - HCW Biologics Registration statement: Registration filing - Filings
14 days ago - HCW Biologics' TGF-β Trap and IL-15 Fusion is a Novel Moiety to Enhance Immunotherapeutic Activity against Diseased Cells - GlobeNewsWire
19 days ago - HCW Biologics files to sell 1.24M shares of common stock for holders - TheFly